Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]
Bio2RDF identifier
NCT00006054
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00006054
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
OBJECTIVES: I. Provide ...... ctional immunoreconstitution.
brief title [clinicaltrials_vocabulary:brief-title]
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
completion date [clinicaltrials_vocabulary:completion-date]
2002-12-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
PROTOCOL OUTLINE: Patie ...... d by their primary physician.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2000-07-05T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Chediak-Higashi syndrome
Langerhans cell histiocytosis
Wiskott-Aldrich syndrome
X-linked agammaglobulinemia
X-linked hyper IgM syndrome
X-linked lymphoproliferative syndrome
chronic granulomatous disease
common variable immunodeficiency
complement deficiency
disease-related problem/condition
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2009-10-14T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00006054
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2002-12-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
UMN-MT-1995-26
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2000-03-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2003-10-01T00:00:00Z
identifier
clinicaltrials:NCT00006054
title
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
@en
type
label
Allogeneic Bone Marrow Transpl ...... s [clinicaltrials:NCT00006054]
@en